March 23 (Reuters) - EU Medicines Agency:
* RECOMMENDS APPROVAL OF CLOVIS ONCOLOGY OVARIAN CANCER DRUG RUBRACA
* EU MEDICINES AGENCY SAYS RECOMMENDED GRANTING A CONDITIONAL MARKETING AUTHORISATION FOR CLOVIS OVARIAN CANCER DRUG RUBRACA Source text - (bit.ly/2pBz519) Further company coverage: